A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM

NCT03493061 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Colo-rectal Cancer
Liver Metastases

Interventions

DRUG: Irinotecan
DRUG: Oxaliplatin
DRUG: Floxuridine

Sponsor

Sun Yat-sen University